To qualify for a medical cannabis prescription in Texas, you must be a permanent resident of the state and have one of the following conditions:

  • ALS,
  • Alzheimer’s disease,
  • Autism,
  • Cerebral Palsy,
  • Chronic Traumatic Brain Encephalopathy,
  • Epilepsy and other Seizure disorders,
  • Huntington’s disease,
  • Multiple Sclerosis,
  • Muscular Dystrophy,
  • Parkinson’s disease,
  • Peripheral Neuropathies,
  • PTSD (beginning 9/1/2021)
  • Muscle Spasms,
  • Spasticity,
  • Spinal Muscular Atrophy,
  • Terminal Cancer (all cancers beginning 9/1/2021)
  • or Incurable Neurodegenerative Diseases.

The Texas Administrative Code defines an incurable neurodegenerative disease as a condition, injury, or illness: (1) that occurs when nerve cells in the brain or peripheral nervous system lose function over time; and (2) for which there is no known cure.

Full list of Incurable Neurodegenerative Diseases

  • 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
  • 5-aminoimidazole-4-carboxamide ribonucleotide transformylase deficiency;
  • Adenylosuccinate synthase Deficiency
  • Alexander disease
  • Alpers-Huttenlocher syndrome
  • Alpha-fucosidosis
  • Alzheimer’s Disease
  • Amyloidoses
  • Amyotrophic lateral Sclerosis
  • Argyrophilic Grain Disease
  • Aromatic L-amino acid decarboxylase deficiency
  • Asparylglucosaminuria
  • Ataxia neuropathy spectrum
  • Bidirectional enzyme deficiency
  • Canavan disease
  • Central Core Muscular Dystrophy
  • Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy
  • Charcot Marie Tooth and related hereditary neuropathies
  • Childhood Myocerebrohepatopathy spectrum
  • Chronic Traumatic Encephalopathy
  • Congenital Disorders of Glycosylation
  • Corticobasal Degeneration
  • Creatine Transporter Defect, also known as SLC 6A8
  • Creutzfeldt-Jakob Disease
  • Dementia with Lewy Bodies
  • Deoxyguanisine kinase deficiency
  • Dihydropirimidinase DeficiencyDihydropyrimidine dehydrogenase Deficiency
  • Dihydropteridine reductase defect
  • Duchenne Muscular Dystrophy
  • Facioscapulohumeral Muscular Dystrophy
  • Familial or Sporadic Fatal Insomnia
  • Familial Spastic Paraplegia
  • Farber Disease
  • Freidreich’s Ataxia
  • Frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in MAPT gene
  • Frontotemporal Lobar Degeneration
  • Galactosemia
  • Galactosialidosis
  • Gaucher Type 2 and Type 3
  • Gerstmann-Straussler-Scheinker Disease
  • Globular Glial Tauopathy
  • Glutaric acidemia type 1
  • Glycine encephalopathy, also known as non-ketotic hyperglycinemia
  • Glycogen Storage-Lysosomal: Pompe Disease
  • GM1 gangliosidosis
  • GM2 gangliosidosis, also known as Tay-Sachs and Sandhoff Disease
  • Guanidinoacetate methytransferase deficiency
  • Guanosine triphosphate cyclohydrolase deficiency
  • Homocysteine re-methylation defects
  • Hunter Syndrome
  • Hurler Syndrome
  • Hypoxanthine-guanine phosophoribosyltransferase Deficiency, also known as Lesch-Nyhan disease
  • Kearn Sayers Syndrome
  • Krabbe
  • Kuru
  • L-2-hydroxyglutaric aciduria
  • L-Arginine/glycine amidinotransferase deficiency
  • Leigh syndrome
  • Lesch-Nyhan
  • leukodystrophy
  • Lewy Body Disorders
  • Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency
  • Lysosomal Storage Diseases
  • Mannosidosis
  • Manosidosis alpha and beta
  • Maple Syrup Urine Disease
  • Metachromatic leukodystrophy
  • Methylenetetrahydrofolate reductase deficiency severe variant
  • Mitochondrial Depletion syndromes types 1 through 14
  • Mitochondrial Encephalopathy Lactic Acidosis Stroke
  • Mitochondrial Encephalopathy Ragged Red Fiber
  • Mitochondrial neurogastrointestinal encephalopathy
  • Monoamine oxidase deficiency
  • Mucolipidoses
  • Mucolipidoses Type II, also known as Inclusion Cell disease
  • Mucolipidoses Type III, also known as pseudo-Hurler polydystrophy
  • Mucopolysaccaridosis
  • Mucopolysaccharidosis Type I, also known as Hurler Syndrome or Scheie Syndrome
  • Mucopolysaccharidosis Type II, also known as Hunter Syndrome
  • Mucopolysaccharidosis Type III, also known as Sanfilippo A and B
  • Mucopolysaccharidosis Type IV, also known as Maroteaux-Lamy
  • Mucopolysaccharidosis Type VII, also known as Sly
  • Multiple Sulfatase deficiency Myoclonic epilepsy myopathy sensory ataxia
  • Multiple System Atrophy
  • Neimann Pick Type A and B
  • Neimann Pick Type C
  • Neonatal Adrenoleukodystrophy
  • Neurodegeneration with brain iron accumulation
  • Neurofibrillary Tangle dementia, also known as Primary Age-related Tauopathy
  • Neuronal ceroid lipofuscinosis types 1-10 including Batten Disease
  • Neuropathy, Ataxia, and Retinitis Pigmentosa
  • Oligosaccharidoses
  • Pantothenate Kinase Associated Neurodegeneration
  • Parkinson’s Disease
  • Pelizaeus-Merzbacher disease
  • Peripheral neuropathy types 1 through 4
  • Peroxisomal biosynthesis defects
  • Pick Disease
  • Polyol disorders
  • Pompe Disease
  • Primary Age-related Tauopathy
  • Primary Lateral Sclerosis
  • Prion Diseases
  • Progressive Choreas: Huntington’s Disease
  • Progressive dystonias DYT genes 1 through 20
  • Progressive Muscular Atrophy
  • Progressive Supranuclear Palsy
  • Pterin-4-carbinolamine dehydratase defect
  • Pyruvate Carboxylase Deficiency
  • Pyruvate Dehydrogenase Deficiency
  • Pyruvoyl-tetahydropterin synthase defect
  • Refsum Disease
  • Respiratory chain disorders complex 1 through 4 defects: Co Q biosynthesis defects
  • RRM2B-related mitochondrial disease
  • Salidosis
  • Sandhoff Disease
  • Sanfilippo A and B
  • Scheie Syndrome
  • Schindler
  • Segawa Diease, also known as Dopamine Responsive Dystonia
  • Sepiapterin reductase defect
  • Sialidosis
  • SLC 6A8
  • Sly
  • Spinal Muscular Atrophy
  • Spinal-bulbar muscular atrophy
  • Spinocerebellar ataxia
  • Subacute necrotizing encephalopathy, also known as Leigh syndrome
  • SUCLG1-related mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
  • Tay-Sachs
  • Thymidine Kinase
  • Transactive response DNA-binding protein-43 (TDP-43) Proteinopathies
  • Trifunctional protein deficiency
  • Vascular dementia
  • Wilson Disease
  • X-linked adrenoleukodystrophy
  • Zellweger syndrome

 

A treating physician of a patient suffering from an incurable neurodegenerative disease not listed in subsection (b) of this section may submit a request to the department to have a disease added.

 

*Source: 25 Texas Administratice Code 1, §1.61

Get a Little Closer

Subscribe

Sign up to get the latest information on sales, new releases, and more…